Vector Development

Tumor-Targetting Salmonella Vector Data Reported

Published in Gene Therapy Weekly, November 15th, 1999

Vion Pharmaceuticals, Inc., New Haven, Connecticut, presented preclinical data of an armed Tapet vector, the company's drug delivery platform for the potential treatment of cancer, at the 14th Annual Meeting of the Society for Biological Therapy, held in Cambridge, Massachusetts, October 30, 1999.

The abstract, titled "Tumor-Selective Salmonella as a Gene Delivery Vector for Cancer Gene Therapy," recently published in the October 12, 1999, issue of the Journal of Immunotherapy, highlights that in preclinical studies, Tapet was useful for delivering therapeutic proteins selectively into tumors, and that one armed Tapet strain caused complete tumor regression in an...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1999-11-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry